| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |